Cited by 119Antifungal resistance and susceptibilityFungal Infections and StudiesInfective Endocarditis Diagnosis and Management

Contribution of serological tests and blood culture to the early diagnosis of systemic candidiasis

Yera, H., Sendid, B., Francois, N., Camus, D., Poulain, D.·2001·European Journal of Clinical Microbiology and Infectious Diseases

Abstract

The isolation of Candida species from a single blood culture is considered sufficient evidence for the initiation of systemic antifungal therapy. However, blood cultures still lack sensitivity. Previous reports have suggested that the combined serological detection of mannanemia and anti-mannan antibodies may be useful for the diagnosis of systemic candidiasis caused by Candida albicans (specificity and sensitivity 93% and 80%, respectively). In this study, serological tests to detect Candida albicans mannan and Candida albicans antibodies (Platelia Candida Antigen and Antibody tests; Bio-Rad, France) were applied retrospectively to a series of patients with at least one Candida-positive blood culture and from whom at least one serum sample, taken before or on the day of blood culture, was available. Forty-five patients were selected, including 23 infected by Candida albicans, 4 by Candida glabrata, 9 by Candida tropicalis, 5 by Candida parapsilosis, and 4 by Candida krusei. Serological tests were positive in 73% of patients at least 2 days, and in some patients, up to 15 days before blood cultures became positive. These data suggest that serological surveillance of at-risk patients using the Platelia Candida tests could result in earlier initiation of antifungal therapy, especially when used in conjunction with blood cultures. In this way, more efficient management of nosocomial infections caused by Candida species can be achieved.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1007/s100960100629

Cites

39 of 39 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • In a follow-up study of patients with candidemia, 33 of 45 (73%) had positive serology using the Platelia assay for mannan antigen or antimannan antibodies at least 2 days before a positive blood culture, with a mean positive serologic test 6 days before positive blood culture.

    “A follow-up study of patients with candidemia revealed that 33 of 45 (73%) patients had positive serology using the Platelia assay for mannan antigen or antimannan antibodies at least 2 days before having a positive blood culture, with a mean positive serologic test 6 days before positive blood culture.62”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 2

  1. Sendid B, Poirot JL, Tabouret M, Bonnin A, Caillot D, Camus D, Poulain D: Combined detection of mannanemia and anti- mannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species. Journal of Medical Microbiology (2001) in press
  2. Odds FC: Candida and candidiasis. A review and bibliogra- phy. Baillière-Tindall, London (1988) pp 206-222

Cited by

Sorted by citations

Authors
Yera, H., Sendid, B., Francois, N., Camus, D., & Poulain, D.
Affiliations
  • Université de Lille (FR)
  • Centre Hospitalier Universitaire de Lille (FR)
Corresponding author
Poulain, D.
Venue
European Journal of Clinical Microbiology and Infectious Diseases
Published
2001-12
Volume
20
Issue
12
Pages
864-870
ISSN
  • 0934-9723 (ISSN-L)
  • 1435-4373
OpenAlex
W2036775339
Cited by
119
References
39
Citations by year
2026: 1 · 2023: 4 · 2021: 2 · 2020: 4 · 2019: 6 · 2018: 3 · 2017: 2 · 2016: 3 · 2015: 5 · 2014: 3 · 2013: 7 · 2012: 3
FWCI
4.86
Type
journal article
Language
en
Open access
closed
Locations
  • European Journal of Clinical Microbiology & Infectious Diseases (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
  • Health Sciences › Medicine › Epidemiology › Fungal Infections and Studies
  • Health Sciences › Medicine › Epidemiology › Infective Endocarditis Diagnosis and Management
Keywords
systemic candidiasis, Candida albicans, serological diagnosis, anti-mannan antibodies, blood culture, early diagnosis, Candida glabrata, Candida tropicalis, Candida parapsilosis, Candida krusei, nosocomial fungal infections, serological surveillance
MeSH terms
Candidiasis, Female, Humans, Male, Middle Aged, Serologic Tests, Fungemia

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review